Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 8Recruiting 6Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 11Gastrointestinal 6Genitourinary 5Sarcoma 4CNS 4Breast 4Lymphoid 3Head & Neck 3Other hematologic neoplasm 2Myeloid 2Endocrine 2Dermatologic 2Plasma cell 1Other neoplasm 1Gynecologic 1Classical hematology 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 392Bortezomib 245Lenalidomide 220Cyclophosphamide 184Melphalan 168Calcium Dobesilate 119Peripheral Blood Stem Cell Transplantation 94fludarabine phosphate 89Thalidomide 82Filgrastim 74carfilzomib 70pomalidomide 68Granulocyte Colony-Stimulating Factor 63Busulfan 63Mycophenolic Acid 61daratumumab 57Whole-Body Irradiation 57ixazomib 54fludarabine 52Tacrolimus 52Prednisone 51Cyclosporine 50Antilymphocyte Serum 35dexamethasone acetate 32plerixafor 30Etoposide 30Methotrexate 29Radiotherapy 28dexamethasone 21-phosphate 27Doxorubicin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × X-Rays × Plasma cell × Clear all
NCT03311828 2024-03-12

Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma

City of Hope Medical Center

Phase 1 Completed
12 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡